Systemic Therapy De-Escalation in Early-Stage Triple-Negative Breast Cancer: Dawn of a New Era? is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0. It has been cited 29 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Center for Advancing Translational Sciences of the National Institutes of Health
Grant: KL2TR001413, UL1TR001412
NIH grants
Grant: R37CA248018, R01CA250412, R01CA251545, R01EB029596
US Department of Defense BCRP grants
Grant: W81XWH-19-1-0674, W81XWH-19-1-0111
DOD/CDMRP Breakthrough Level 4 Award
Grant: W81XWH-19-1-0674
NCATS NIH HHS
Grant: UL1 TR001412
NCATS NIH HHS
Grant: KL2 TR001413
National Institutes of Health
Grant: 5R37CA248018-04
Leveraging the GTP Biosynthetic Pathway for Anti-Tumor Therapies
National Institutes of Health
Grant: 5R01EB029596-03
Multiparametric photoacoustic and ultrasonic imaging of the breast in cranial-caudal view
National Institutes of Health
Grant: 5R01CA251545-02
Functional Significance of individual p53 mutations in determining the role of estrogen receptor beta in triple negative breast cancer
National Institutes of Health
Grant: 5KL2TR001413-03
Buffalo Clinical and Translational Research Center
National Institutes of Health
Grant: 3UL1TR001412-08S3
Buffalo Clinical and Translational Research Center
National Institutes of Health
Grant: 5R01CA250412-02
Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity
FWCI
2.42
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Pan-inhibition of the three H2S synthesizing enzymes restrains tumor progression and immunosuppression in breast cancer
Additional file 1 of Pan-inhibition of the three H2S synthesizing enzymes restrains tumor progression and immunosuppression in breast cancer